BGSF, INC.
For the period ended Dec 29, 2024. Filed Mar 17, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 17, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Selected Financial Data
The following tables set forth our summary consolidated historical financial data from continuing operations. You should read the information set forth below in conjunction with “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated historical financial statements and notes thereto included elsewhere in this Annual Report on Form 10-K. The statement of operations data for the fiscal years ended 2024, 2023, and 2022 and the balance sheet data as of December 29, 2024 and December 31, 2023 set forth below are derived from our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K. The statement of operations data for the fiscal years ended 2021 and 2020 and the balance sheet data as of January 1, 2023, December 26, 2021, and December 27, 2020 set forth below were derived from our audited financial statements not included in this Annual Report on Form 10-K.
| Fiscal Years Ended | |||||
|---|---|---|---|---|---|
| December 29,2024 | December 31,2023 | January 1,2023 | December 26,2021 | December 27,2020 | |
| (dollars in thousands, except per share data) | |||||
| Statement of Operations Data: | |||||
| Revenues | $272,499 | $313,167 | $298,422 | $239,027 | $207,125 |
| Gross profit | $92,863 | $111,784 | $103,548 | $80,941 | $66,040 |
| Selling, general, and administrative expenses | $85,333 | $88,650 | $83,211 | $65,116 | $55,244 |
| Gain on contingent consideration | $(1,452) | $— | $— | $(2,403) | $(76) |
| Impairment losses | $— | $22,545 | $— | $— | $7,240 |
| Depreciation and amortization | $7,769 | $7,774 | $4,054 | $3,698 | $4,861 |
| Operating income (loss) | $1,213 | $(7,185) | $16,283 | $14,530 | $(1,229) |
| Interest expense, net | $(4,921) | $(5,976) | $(1,363) | $(1,433) | $(1,584) |
| (Loss) income before income taxes from continuing operations | $(3,708) | $(13,161) | $14,920 | $13,097 | $(2,813) |
| Income tax benefit (expense) from continuing operations | $370 | $2,938 | $(3,659) | $(2,639) | $741 |
| (Loss) income from continuing operations | $(3,338) | $(10,223) | $11,261 | $10,458 | $(2,072) |
| Income from discontinued operations, net of tax | $— | $— | $14,100 | $3,651 | $3,513 |
| Net (loss) income | $(3,338) | $(10,223) | $25,361 | $14,109 | $1,441 |
| Net (loss) income per share - basic: | |||||
| Continuing operations | $(0.31) | $(0.95) | $1.08 | $1.01 | $(0.20) |
| Income from discontinued operations: | |||||
| Income | — | — | 0.12 | 0.44 | 0.46 |
| Gain on Sale | — | — | 1.69 | — | — |
| Income tax expense | — | — | (0.46) | (0.09) | (0.12) |
| Net (loss) income per share – basic | $(0.31) | $(0.95) | $2.43 | $1.36 | $0.14 |
| Net (loss) income per share - diluted: | |||||
| Continuing operations | $(0.31) | $(0.95) | $1.07 | $1.00 | $(0.20) |
| Income from discontinued operations: | |||||
| Income | — | — | 0.12 | 0.44 | 0.46 |
| Gain on Sale | — | — | 1.69 | — | — |
| Income tax expense | — | — | (0.46) | (0.09) | (0.12) |
| Net (loss) income per share – diluted | $(0.31) | $(0.95) | $2.42 | $1.35 | $0.14 |
| Weighted average shares outstanding – basic | 10,896 | 10,766 | 10,427 | 10,367 | 10,312 |
| Weighted average shares outstanding – diluted | 10,896 | 10,766 | 10,473 | 10,417 | 10,338 |
| Fiscal Years Ended | |||||
|---|---|---|---|---|---|
| December 29,2024 | December 31,2023 | January 1,2023 | December 26,2021 | December 27,2020 | |
| (dollars in thousands, except per share data) | |||||
| Other Financial Data: | |||||
| Adjusted EBITDA from continuing operations(1) | $10,475 | $25,858 | $22,353 | $15,288 | $12,350 |
| Same Day EBITDA from continuing operations(1) | $10,475 | $25,858 | $21,943 | $15,288 | $12,350 |
| Cash dividends declared per common share | $0.15 | $0.60 | $0.60 | $0.44 | $0.50 |
| Balance Sheet Data from Continuing Operations: | |||||
| Working capital(2) | $19,427 | $(18,144) | $47,955 | $25,851 | $17,960 |
| Total assets | $150,111 | $178,517 | $194,673 | $148,294 | $130,278 |
| Total outstanding borrowings, net | $46,321 | $63,114 | $66,671 | $39,450 | $34,634 |
| Total other long-term liabilities | $3,770 | $7,926 | $3,059 | $7,240 | $14,224 |
| Stockholders’ equity | $82,269 | $85,536 | $100,736 | $76,592 | $65,458 |
(1)We present Adjusted EBITDA and Same Day EBITDA (defined below), measure that are not in accordance with accounting principles generally accepted in the United States of America (“non-GAAP”), in this Annual Report on Form 10-K to provide investors with a supplemental measure of our operating performance. We believe that Adjusted EBITDA and Same Day EBITDA are useful performance measures and are used by us to facilitate comparisons of our operating performance on a consistent basis from period-to-period and to provide for a more complete understanding of factors and trends affecting our business than measures under accounting principles generally accepted in the United States of America (“GAAP”) can provide alone. Our board and management also use Adjusted EBITDA and Same Day EBITDA as one of the primary methods for planning and forecasting overall expected performance and for evaluating on a quarterly and annual basis actual results against such expectations, and as a performance evaluation metric in determining achievement of certain compensation programs and plans for our management. In addition, the financial covenants in our credit agreement are based on EBITDA as defined in the credit agreement.
(2)The 2023 working capital amount includes the movement of the balances from long-term to current liabilities related to the amended credit agreement with BMO Harris Bank, N.A. (“BMO”), which had a maturity date of July 16, 2024.
We define “Adjusted EBITDA” as earnings before interest expense, income taxes, depreciation and amortization expense, impairment losses, costs associated with the evaluation of potential strategic alternatives (“Strategic alternatives review”), transaction fees, software as a service costs, and certain non-cash expenses such as share-based compensation expense. Omitting interest, taxes and the other items provides a financial measure that facilitates comparisons of our results of operations with those of companies having different capital structures. Since the levels of indebtedness and tax structures that other companies have are different from ours, we omit these amounts to facilitate investors’ ability to make these comparisons. Similarly, we omit depreciation and amortization because other companies may employ a greater or lesser amount of property and intangible assets. We also believe that investors, analysts, and other interested parties view our ability to generate Adjusted EBITDA as an important measure of our operating performance and that of other companies in our industry. Adjusted EBITDA should not be considered as an alternative to net income for the periods indicated as a measure of our performance. Other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure.
We define “Same Day EBITDA” as Adjusted EBITDA on a fifty-two week fiscal year basis. Omitting the additional revenue days in a fifty-three week fiscal year ended provides a financial measure that facilitates comparisons of our results of operations with those of our fifty-two week fiscal year and comparisons of our results with those companies having same number of days. Same Day EBITDA should not be considered as an alternative to net income for the periods indicated as a measure of our performance. Other companies in our industry may calculate Adjusted EBITDA or Same Day EBITDA differently than we do, limiting their usefulness as comparative measures.
The use of Adjusted EBITDA and Same Day EBITDA have limitations as analytical tools, and you should not consider these performance measure in isolation from, or as an alternative to, GAAP measures such as net income. Adjusted EBITDA and Same Day EBITDA are not measures of liquidity under GAAP or otherwise, and are not alternatives to cash flow from continuing operating activities. Our presentation of Adjusted EBITDA and Same Day EBITDA should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items. The limitations of Adjusted EBITDA and Same Day EBITDA include: (i) they do not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments; (ii) they do not reflect changes in, or cash requirements for, our working capital needs; (iii) they do not reflect income tax payments we may be required to make; and (iv) they do not reflect the cash requirements necessary to service interest or principal payments associated with indebtedness.
To properly and prudently evaluate our business, we encourage you to review our consolidated financial statements included elsewhere in this Annual Report on Form 10-K and the reconciliation to Adjusted EBITDA and Same Day EBITDA from net (loss) income, the most directly comparable financial measure presented in accordance with GAAP, set forth in the following table. All of the items included in the reconciliation from net income to Adjusted EBITDA are either (i) non-cash items or (ii) items that management does not consider in assessing our on-going operating performance. In the case of the non-cash items, management believes that investors may find it useful to assess our comparative operating performance because the measures without such items are less susceptible to variances in actual performance resulting from depreciation, amortization and other non-cash charges and more reflective of other factors that affect operating performance. In the case of the other items that management does not consider in assessing our on-going operating performance, management believes that investors may find it useful to assess our operating performance if the measures are presented without these items because their financial impact may not reflect ongoing operating performance.
| Fiscal Years Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| December 29,2024 · December 31,2023 · January 1,2023 · December 26,2021 · December 27,2020 | |||||||||||
| (dollars in thousands) | |||||||||||
| (Loss) income from continuing operations | $(3,338) | $(10,223) | $11,261 | $10,458 | $(2,072) | ||||||
| Income tax (benefit) expense from continuing operations(1) | (370) | (2,938) | 3,659 | 2,639 | (741) | ||||||
| Interest expense, net | 4,921 | 5,976 | 1,363 | 1,433 | 1,584 | ||||||
| Operating income (loss) | 1,213 | (7,185) | 16,283 | 14,530 | (1,229) | ||||||
| Depreciation and amortization | 7,769 | 7,774 | 4,054 | 3,698 | 4,861 | ||||||
| Gain on contingent consideration | (1,452) | — | — | (2,403) | (76) | ||||||
| Impairment losses(2) | — | 22,545 | — | — | 7,240 | ||||||
| CARES Act credit | — | — | — | (2,084) | — | ||||||
| Share-based compensation | 989 | 1,029 | 1,085 | 1,058 | 786 | ||||||
| Strategic alternatives review | 962 | — | — | — | — | ||||||
| Cost restructuring plan | 230 | — | — | — | — | ||||||
| Software as a service(3) | 716 | 720 | 660 | 319 | 153 | ||||||
| Transaction fees | 48 | 975 | 271 | 170 | 615 | ||||||
| Adjusted EBITDA from continuing operations | 10,475 | 25,858 | 22,353 | 15,288 | 12,350 | ||||||
| Same day adjustment | — | — | (410) | — | — | ||||||
| Same day EBITDA from continuing operations | $10,475 | $25,858 | $21,943 | $15,288 | $12,350 | ||||||
(1)2020 Included a $3.3 million re-measurement of the net deferred tax assets as a result of the TCJA.
(2)In the Professional segment, we recognized a $3.7 million trade name impairment loss and a $3.5 million client partner list impairment loss during the thirteen week period ended June 28, 2020. We recognized a $22.5 million trade name impairment loss during the thirteen week period ended April 2, 2023.
(3)We capitalizes direct costs incurred in cloud computing implementation costs from hosting arrangements, which are reported as a Software as a service and are expensed as incurred in selling, general and administrative expenses.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.